3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
CNS
13
Sarcoma
10
Other hematologic neoplasm
2
Lymphoid
2
Genitourinary
2
Thoracic
1
Plasma cell
1
Other solid neoplasm
1
NET
1
Myeloid
1
Head & Neck
1
Gynecologic
1
Gastrointestinal
1
Endocrine
1
Dermatologic
1
Breast
1
Conditions
Ovarian Neoplasms
45
Uterine Cervical Neoplasms
22
Fallopian Tube Neoplasms
20
Carcinoma, Ovarian Epithelial
15
Neoplasms
8
Endometrial Neoplasms
8
Lung Neoplasms
7
Breast Neoplasms
5
Stomach Neoplasms
4
Recurrence
4
Pancreatic Neoplasms
4
Neoplasm Metastasis
4
Melanoma
4
Head and Neck Neoplasms
4
Gestational Trophoblastic Disease
4
Vulvar Neoplasms
3
Peritoneal Neoplasms
3
Kidney Neoplasms
3
Esophageal Neoplasms
3
Colorectal Neoplasms
3
Uterine Neoplasms
2
Sarcoma
2
Lymphoma, Non-Hodgkin
2
Liver Neoplasms
2
Laryngeal Neoplasms
2
Hydatidiform Mole
2
Gynecologic Cancer
2
Glioblastoma
2
Colonic Neoplasms
2
Cholangiocarcinoma
2
Interventions
Paclitaxel
8
Filgrastim
8
Carboplatin
8
Peripheral Blood Stem Cell Transplantation
6
Ifosfamide
6
Etoposide
4
Temozolomide
3
pembrolizumab
2
pegfilgrastim
2
ixabepilone
2
etoposide phosphate
2
Thiotepa
2
Melphalan
2
Gemcitabine
2
Cisplatin
2
Amifostine
2
sodium thiosulfate
1
regorafenib
1
carboxyamido-triazole
1
aflibercept
1
Trabectedin
1
Topotecan
1
Taxes
1
Surveys and Questionnaires
1
Restraint, Physical
1
Radiotherapy
1
Quality of Life
1
Psychiatric Rehabilitation
1
Patient Reported Outcome Measures
1
PT-100 dipeptide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Central Nervous System Neoplasms
×
Drug Therapy
×
Gynecologic
×
Clear all
NCT04028479
2024-12-18
ROOT
Taproot Health
Completed
167 enrolled